Adam Brufsky, MD, PhD, is Professor of Medicine at the University of Pittsburgh Medical Center Health System and Director of the Magee Women’s Hospital/University of Pittsburgh Cancer Institute Comprehensive Breast Care Center. He is also Associate Chief of the Division of Hematology/Oncology. and Associate Director for Clinical Investigation for the University of Pittsburgh Cancer Institute.
Dr. Brufsky’s major research interests include novel therapeutic clinical trials in breast cancer, novel agents (including anti-angiogenic agents) in metastatic breast cancer, genomics of resistance and response in metastatic breast cancer, and bone-breast cancer interactions in early and advanced breast cancer.
He received his medical and doctorate degrees in developmental biology from the University of Connecticut School of Medicine in 1990. He completed his postdoctoral training at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute. He was Instructor in Medicine at Harvard Medical School prior to joining the faculty at the University of Pittsburgh in 1996.
Dr. Brufsky has authored or co-authored over 200 peer reviewed original manuscripts, reviews, and abstracts in such journals as the Journal of Clinical Oncology, Journal of Clinical Investigation, Cancer, New England Journal of Medicine, Nature, and Clinical Cancer Research.